GSD.V Devonian Health Group Inc.

P/E --
Forward P/E --
Price/Sales 7.659478
Beta 1.138
Div Yield 0.0%
Market Cap --

Company Analysis

Latest News

🔴 Devonian Health Group is trading 5% down

Devonian Health Group is trading 5.33% down at CA$7.10 on October 16, 2026, with no company-specific announcement identified to explain the decline. - Sector...

🔴 Devonian Health Group is trading 6.25% down; no clear company-specific explanation identified

Devonian Health Group is trading at CA$7.50, down 6.25%; no clear company-specific announcement explaining the October 14, 2026 decline was found. - The...

🔴 Devonian Health Group is trading 9.09% down today

Devonian Health Group is trading 9.09% lower at CA$7.50, with no clear catalyst identified. - Available search results show no company announcement dated...

🟢 Devonian Health Group is trading 11.94% up; no clear catalyst identified

Devonian Health Group is trading 11.94% up at CA$7.50 on October 8, 2026, with no clear company-specific catalyst identified. - The latest surfaced company...

🔴 Devonian Health Group is trading 12.5% down with no identified company-specific catalyst

Devonian Health Group is trading at CA$7.00, down 12.50%; no clear company-specific announcement or catalyst for the October 6 decline was identified in...

🔴 Devonian Health Group is trading 8.4% down — reason remains unclear

Devonian Health Group is trading 8.4% lower at CA$8.20 on October 1, 2026, with the reason for the decline unclear. - Price context shows a decline from...

🔴 Devonian Health Group is trading 11% down today amid disappointing trial news and analyst downgrades

Devonian Health Group is trading 11% down at $8.01 as biotech-sector weakness intensified during September 15, 2026 trading. - Biotech sentiment weakened...

Devonian Jumps to U.S. Markets With a Stock Offering and Big Ambitions — But Can a Cash-Burning Biotech Justify the Hype?

Devonian Jumps to U.S. Markets With a Stock Offering and Big Ambitions — But Can a Cash-Burning Biotech Justify the Hype?

Shares of Devonian Health Group (TSXV: GSD) surged +12.5% to $9.00 on September 14 as the Quebec-based biotech prepares for what could be a defining week. The...

🟢 Devonian Health Group is trading 12.5% up today amid proposed NYSE American listing

Devonian Health Group is trading at $9.00, +12.50%, amid plans for a potential NYSE American listing. - On September 11, 2026, the company announced its...

🟢 Devonian Health Group is trading 12.64% up today

Devonian Health Group is trading 12.64% up now at $9.00, with no verified September 9, 2026 company-specific announcement or explicit catalyst identified for...

🔴 Devonian Health Group is trading 18.45% down today with no clear company-specific catalyst identified

Devonian Health Group is trading at $8.00 (-18.45%) now, with no clear company-specific catalyst identified for September 8, 2026. • No verified September 8...

🟢 Devonian Health Group is trading 9% up today as biotech sector gains 2.75%

Devonian Health Group is trading at $9.81, with a +9.00% change as the broader biotech sector gains 2.75% during the September 2, 2026 session. - No fresh...

🔴 Devonian Health Group is trading 11.36% down today with no identified company-specific catalyst

Devonian Health Group is trading 11.36% down at CA$9.75 after opening-day selling from the previous CA$11.00 close, amid recent biotech-sector weakness and a...

🔴 Devonian Health Group is trading 10.82% down today amid broader biotech-sector weakness

Devonian Health Group is trading 10.82% down now at CA$9.81, with the decline appearing primarily aligned with broader biotech-sector weakness and caution...

🔴 Devonian Health Group is trading 18.18% down; no company-specific catalyst identified

Devonian Health Group is trading 18.18% down now at CA$9.00 on August 28, 2026, with no credible company-specific announcement explaining the decline found in...

🔴 Devonian Health Group is trading 6.67% down today after sharp gains

Devonian Health Group is trading at CA$11.20, down 6.67%, after sharp gains over the prior three sessions. - No new company-specific announcement explaining...

🔴 Devonian Health Group is trading 8.97% down today after gains tied to planned NYSE American listing

Devonian Health Group is trading at CA$10.15, down -8.97%, with no new company-specific announcement identified to explain the August 20, 2026 decline. - The...

🟢 Devonian Health Group is trading 10.4% up today after confirming a potential NYSE American listing

Devonian Health Group is trading 10.4% up at CA$11.15 after confirming on August 18, 2026, that its shares and warrants could begin trading on NYSE American as...

Devonian Jumps 14% on NYSE American Bid — But Can a $19M Offering Fund a Clinical-Stage Biotech's Long Road to Revenue?

Devonian Jumps 14% on NYSE American Bid — But Can a $19M Offering Fund a Clinical-Stage Biotech's Long Road to Revenue?

Shares of Devonian Health Group (TSXV: GSD) surged 14% to $9.06 on August 18, breaking out of a flat $7.75 range held for nearly a week, after the Quebec-based...

🟢 Devonian Health Group is trading 14% up today after announcing potential NYSE American debut

Devonian Health Group is trading 13.96% up now at $9.06 after announcing on August 18, 2026, that its shares and warrants could begin trading on NYSE American...